SecBot SecBot
8-K ·Filed May 5, 2026

DVA

DAVITA INC.
BULLISH
Impact 8/10
Horizondays Processed6mo ago SEC0000927066-26-000060
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong beat and raised guidance confirm DaVita's operational execution. Monitor for potential upside to FY guidance as the year progresses; the continued buyback supports EPS growth. Competitor FMS may also benefit from positive sector sentiment.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$191.76
T+0 close · May 5, 2026 · via day close
Latest settled
+24.56%
T+60 · $238.86
Vs SPY
+23.49%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $191.76entry
  2. T+1 · 6mo ago +1.87%α +2.20% · $195.35
  3. T+5 · 6mo ago +4.58%α +3.45% · $200.54
  4. T+20 · 6mo ago +1.71%α −1.07% · $195.03
  5. T+60 · 4mo ago +24.56%α +23.49% · $238.86

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

DaVita reported Q1 2026 revenue of $3.416B (+6% YoY) and GAAP diluted EPS of $2.87, beating the Street consensus of $2.41 by 19%. The company raised its FY2026 adjusted EPS guidance to $14.10-$15.20 from $13.60-$15.00, signaling sustained operating momentum and margin expansion.

Key Financial Metrics

EPS
$2.87
est $2.41 · +19.1%
Revenue
$3.4B
+6.0% YoY
Rating
strong beat
Free Cash Flow
$140.0M

Key Facts

  • Revenue of $3.416B (+6% YoY) beat consensus.
  • GAAP diluted EPS of $2.86 (actually $2.87) beat Street consensus of $2.41 by 19%.
  • FY2026 adjusted EPS guidance raised to $14.10-$15.20 from $13.60-$15.00.
  • Aggressive buyback: 3.0M shares for $403M in Q1, plus 2.0M for $302M after quarter-end.
  • Integrated kidney care risk-based patients declined to 62,600 from 66,000 sequentially.

Financial Impact

EPS beat by $0.46 vs consensus, revenue beat by ~$56M vs notional consensus, guidance raised at the low end by $0.50.

revenueepsguidance

Risk Factors

  • Declining integrated kidney care patient count may signal challenges in value-based care.
  • Rising operating costs (patient care costs per treatment up 3% YoY) could pressure margins.
  • Potential regulatory changes (Medicare reimbursement, OBBBA) remain unknown.

Market Snapshot

Exchange
NYSE
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
43% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000927066-26-000060
Document: dva-20260505.htm0000927066-26-000060
Document: 0000927066-26-000060-index-headers.html0000927066-26-000060
Document: 0000927066-26-000060-index.html0000927066-26-000060
Document: 0000927066-26-000060.txt0000927066-26-000060
8-K Data (Synthetic)0000927066-26-000060

Track record

9 reports on DVA

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Oct 29, 202618d ago 8-K Mixed 5/10 No price data
  2. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $187.50 Now $174.22 −7.08% settles Jan 28
  3. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $183.64 Now $174.22 −5.13% settles Jan 21
  4. Aug 4, 202614w ago 8-K Bullish 6/10 Entry $187.61 to $193.31 Now $174.22 −7.14% ▲ +3.04% +3.10% vs SPY
  5. Jun 15, 202622w ago Court Ruling Neutral 1/10 Entry $208.98 to $181.55 Now $174.22 −16.63% ▼ −13.13% −14.99% vs SPY
  6. Jun 8, 202623w ago 8-K Mixed 5/10 Entry $198.19 to $178.83 Now $174.22 −12.09% ▼ −9.77% −13.58% vs SPY
  7. May 18, 202626w ago Insider Cluster Neutral 3/10 Entry $194.38 to $179.17 Now $174.22 −10.37% ▼ −7.82% −13.84% vs SPY
  8. May 13, 202626w ago Insider Cluster Bearish 6/10 Entry $192.30 to $183.48 Now $174.22 +9.40% ▲ +4.59% +7.91% vs SPY
  9. May 5, 202627w ago 8-K Bullish 8/10 Viewing Entry $191.76 to $238.86 Now $174.22 −9.15% ▲ +24.56% +23.49% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens Wed (11h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026